Universe Pharmaceuticals INC Operating Cash Flow
Universe Pharmaceuticals INC (UPC) reported Operating Cash Flow of -$5.05 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-01-29
| Period end | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month | Net Cash Provided by (Used in) Operating Activities 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | -$5.05B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | -$9.51B 20-F · filed 2026-01-29 | -$9.51M 20-F · filed 2025-04-29 | |
| 2024-03-31 | -$2.43M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $1.12B 20-F · filed 2026-01-29 | $1.12M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $4.80M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | -$1.30M 20-F · filed 2025-04-29 | -$1.31M 20-F · filed 2023-02-10 | |
| 2022-03-31 | $6.12M 6-K · filed 2023-08-31 | ||
| 2021-09-30 | -$2.06M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $1.06M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $6.12M 20-F · filed 2023-02-10 | ||
| 2019-09-30 | $13.20M 20-F · filed 2022-01-31 |